Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas purchased 38,900 shares of the company’s stock in a transaction on Wednesday, January 22nd. The stock was purchased at an average price of $0.77 per share, with a total value of $29,953.00. Following the completion of the transaction, the chief executive officer now owns 4,203,689 shares of the company’s stock, valued at approximately $3,236,840.53. This trade represents a 0.93 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Grigorios Siokas also recently made the following trade(s):
- On Friday, January 17th, Grigorios Siokas acquired 29,158 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.86 per share, with a total value of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas bought 62,500 shares of Cosmos Health stock. The shares were bought at an average price of $0.80 per share, with a total value of $50,000.00.
- On Monday, January 13th, Grigorios Siokas purchased 163,666 shares of Cosmos Health stock. The shares were purchased at an average price of $0.61 per share, with a total value of $99,836.26.
- On Friday, December 20th, Grigorios Siokas acquired 257,334 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.58 per share, with a total value of $149,253.72.
Cosmos Health Trading Down 0.7 %
Shares of COSM stock opened at $0.78 on Friday. The stock’s 50 day simple moving average is $0.73 and its two-hundred day simple moving average is $0.90. Cosmos Health Inc. has a 1 year low of $0.47 and a 1 year high of $1.58. The company has a market cap of $18.23 million, a PE ratio of -0.32 and a beta of 5.57. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.44 and a quick ratio of 1.24.
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Recommended Stories
- Five stocks we like better than Cosmos Health
- Differences Between Momentum Investing and Long Term Investing
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Overbought Stocks Explained: Should You Trade Them?
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.